1 Endocrinology Drugs Market Overview 1.1 Product Overview and Scope of Endocrinology Drugs 1.2 Endocrinology Drugs Segment by Type 1.2.1 Global Endocrinology Drugs Sales Growth Rate Comparison by Type (2022-2028) 1.2.2 Diabetes Drugs 1.2.3 Testosterone Replacement Drugs 1.2.4 Human Growth Hormone Drugs 1.2.5 Thyroid Hormone Disorder Drugs 1.3 Endocrinology Drugs Segment by Application 1.3.1 Global Endocrinology Drugs Sales Comparison by Application: (2022-2028) 1.3.2 Hospitals 1.3.3 Commercial Laboratories 1.3.4 Ambulatory Care Centres 1.3.5 Other Setting 1.4 Global Endocrinology Drugs Market Size Estimates and Forecasts 1.4.1 Global Endocrinology Drugs Revenue 2017-2028 1.4.2 Global Endocrinology Drugs Sales 2017-2028 1.4.3 Endocrinology Drugs Market Size by Region: 2017 Versus 2021 Versus 2028 2 Endocrinology Drugs Market Competition by Manufacturers 2.1 Global Endocrinology Drugs Sales Market Share by Manufacturers (2017-2022) 2.2 Global Endocrinology Drugs Revenue Market Share by Manufacturers (2017-2022) 2.3 Global Endocrinology Drugs Average Price by Manufacturers (2017-2022) 2.4 Manufacturers Endocrinology Drugs Manufacturing Sites, Area Served, Product Type 2.5 Endocrinology Drugs Market Competitive Situation and Trends 2.5.1 Endocrinology Drugs Market Concentration Rate 2.5.2 The Global Top 5 and Top 10 Largest Endocrinology Drugs Players Market Share by Revenue 2.5.3 Global Endocrinology Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 3 Endocrinology Drugs Retrospective Market Scenario by Region 3.1 Global Endocrinology Drugs Retrospective Market Scenario in Sales by Region: 2017-2022 3.2 Global Endocrinology Drugs Retrospective Market Scenario in Revenue by Region: 2017-2022 3.3 North America Endocrinology Drugs Market Facts & Figures by Country 3.3.1 North America Endocrinology Drugs Sales by Country 3.3.2 North America Endocrinology Drugs Revenue by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe Endocrinology Drugs Market Facts & Figures by Country 3.4.1 Europe Endocrinology Drugs Sales by Country 3.4.2 Europe Endocrinology Drugs Revenue by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Endocrinology Drugs Market Facts & Figures by Region 3.5.1 Asia Pacific Endocrinology Drugs Sales by Region 3.5.2 Asia Pacific Endocrinology Drugs Revenue by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America Endocrinology Drugs Market Facts & Figures by Country 3.6.1 Latin America Endocrinology Drugs Sales by Country 3.6.2 Latin America Endocrinology Drugs Revenue by Country 3.6.3 Mexico 3.6.4 Brazil 3.6.5 Argentina 3.7 Middle East and Africa Endocrinology Drugs Market Facts & Figures by Country 3.7.1 Middle East and Africa Endocrinology Drugs Sales by Country 3.7.2 Middle East and Africa Endocrinology Drugs Revenue by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 U.A.E 4 Global Endocrinology Drugs Historic Market Analysis by Type 4.1 Global Endocrinology Drugs Sales Market Share by Type (2017-2022) 4.2 Global Endocrinology Drugs Revenue Market Share by Type (2017-2022) 4.3 Global Endocrinology Drugs Price by Type (2017-2022) 5 Global Endocrinology Drugs Historic Market Analysis by Application 5.1 Global Endocrinology Drugs Sales Market Share by Application (2017-2022) 5.2 Global Endocrinology Drugs Revenue Market Share by Application (2017-2022) 5.3 Global Endocrinology Drugs Price by Application (2017-2022) 6 Key Companies Profiled 6.1 AbbVie 6.1.1 AbbVie Corporation Information 6.1.2 AbbVie Description and Business Overview 6.1.3 AbbVie Endocrinology Drugs Sales, Revenue and Gross Margin (2017-2022) 6.1.4 AbbVie Endocrinology Drugs Product Portfolio 6.1.5 AbbVie Recent Developments/Updates 6.2 AstraZeneca 6.2.1 AstraZeneca Corporation Information 6.2.2 AstraZeneca Description and Business Overview 6.2.3 AstraZeneca Endocrinology Drugs Sales, Revenue and Gross Margin (2017-2022) 6.2.4 AstraZeneca Endocrinology Drugs Product Portfolio 6.2.5 AstraZeneca Recent Developments/Updates 6.3 Eli Lilly 6.3.1 Eli Lilly Corporation Information 6.3.2 Eli Lilly Description and Business Overview 6.3.3 Eli Lilly Endocrinology Drugs Sales, Revenue and Gross Margin (2017-2022) 6.3.4 Eli Lilly Endocrinology Drugs Product Portfolio 6.3.5 Eli Lilly Recent Developments/Updates 6.4 Merck 6.4.1 Merck Corporation Information 6.4.2 Merck Description and Business Overview 6.4.3 Merck Endocrinology Drugs Sales, Revenue and Gross Margin (2017-2022) 6.4.4 Merck Endocrinology Drugs Product Portfolio 6.4.5 Merck Recent Developments/Updates 6.5 Novo Nordisk 6.5.1 Novo Nordisk Corporation Information 6.5.2 Novo Nordisk Description and Business Overview 6.5.3 Novo Nordisk Endocrinology Drugs Sales, Revenue and Gross Margin (2017-2022) 6.5.4 Novo Nordisk Endocrinology Drugs Product Portfolio 6.5.5 Novo Nordisk Recent Developments/Updates 6.6 Sanofi 6.6.1 Sanofi Corporation Information 6.6.2 Sanofi Description and Business Overview 6.6.3 Sanofi Endocrinology Drugs Sales, Revenue and Gross Margin (2017-2022) 6.6.4 Sanofi Endocrinology Drugs Product Portfolio 6.6.5 Sanofi Recent Developments/Updates 7 Endocrinology Drugs Manufacturing Cost Analysis 7.1 Endocrinology Drugs Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Endocrinology Drugs 7.4 Endocrinology Drugs Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Endocrinology Drugs Distributors List 8.3 Endocrinology Drugs Customers 9 Endocrinology Drugs Market Dynamics 9.1 Endocrinology Drugs Industry Trends 9.2 Endocrinology Drugs Market Drivers 9.3 Endocrinology Drugs Market Challenges 9.4 Endocrinology Drugs Market Restraints 10 Global Market Forecast 10.1 Endocrinology Drugs Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Endocrinology Drugs by Type (2023-2028) 10.1.2 Global Forecasted Revenue of Endocrinology Drugs by Type (2023-2028) 10.2 Endocrinology Drugs Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Endocrinology Drugs by Application (2023-2028) 10.2.2 Global Forecasted Revenue of Endocrinology Drugs by Application (2023-2028) 10.3 Endocrinology Drugs Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Endocrinology Drugs by Region (2023-2028) 10.3.2 Global Forecasted Revenue of Endocrinology Drugs by Region (2023-2028) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Endocrinology Drugs Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million) Table 2. Global Endocrinology Drugs Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million) Table 3. Global Endocrinology Drugs Market Size by Region (US$ Million) (2017 VS 2021 VS 2028) Table 4. Global Endocrinology Drugs Market Competitive Situation by Manufacturers in 2021 Table 5. Global Endocrinology Drugs Sales (K Units) of Key Manufacturers (2017-2022) Table 6. Global Endocrinology Drugs Sales Market Share by Manufacturers (2017-2022) Table 7. Global Endocrinology Drugs Revenue (US$ Million) by Manufacturers (2017-2022) Table 8. Global Endocrinology Drugs Revenue Share by Manufacturers (2017-2022) Table 9. Global Market Endocrinology Drugs Average Price (USD/Unit) of Key Manufacturers (2017-2022) Table 10. Manufacturers Endocrinology Drugs Manufacturing Sites and Area Served Table 11. Manufacturers Endocrinology Drugs Product Type Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Endocrinology Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Endocrinology Drugs as of 2021) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Global Endocrinology Drugs Sales by Region (2017-2022) & (K Units) Table 16. Global Endocrinology Drugs Sales Market Share by Region (2017-2022) Table 17. Global Endocrinology Drugs Revenue by Region (2017-2022) & (US$ Million) Table 18. Global Endocrinology Drugs Revenue Market Share by Region (2017-2022) Table 19. North America Endocrinology Drugs Sales by Country (2017-2022) & (K Units) Table 20. North America Endocrinology Drugs Sales Market Share by Country (2017-2022) Table 21. North America Endocrinology Drugs Revenue by Country (2017-2022) & (US$ Million) Table 22. North America Endocrinology Drugs Revenue Market Share by Country (2017-2022) Table 23. Europe Endocrinology Drugs Sales by Country (2017-2022) & (K Units) Table 24. Europe Endocrinology Drugs Sales Market Share by Country (2017-2022) Table 25. Europe Endocrinology Drugs Revenue by Country (2017-2022) & (US$ Million) Table 26. Europe Endocrinology Drugs Revenue Market Share by Country (2017-2022) Table 27. Asia Pacific Endocrinology Drugs Sales by Region (2017-2022) & (K Units) Table 28. Asia Pacific Endocrinology Drugs Sales Market Share by Region (2017-2022) Table 29. Asia Pacific Endocrinology Drugs Revenue by Region (2017-2022) & (US$ Million) Table 30. Asia Pacific Endocrinology Drugs Revenue Market Share by Region (2017-2022) Table 31. Latin America Endocrinology Drugs Sales by Country (2017-2022) & (K Units) Table 32. Latin America Endocrinology Drugs Sales Market Share by Country (2017-2022) Table 33. Latin America Endocrinology Drugs Revenue by Country (2017-2022) & (US$ Million) Table 34. Latin America Endocrinology Drugs Revenue Market Share by Country (2017-2022) Table 35. Middle East and Africa Endocrinology Drugs Sales by Country (2017-2022) & (K Units) Table 36. Middle East and Africa Endocrinology Drugs Sales Market Share by Country (2017-2022) Table 37. Middle East and Africa Endocrinology Drugs Revenue by Country (2017-2022) & (US$ Million) Table 38. Middle East and Africa Endocrinology Drugs Revenue Market Share by Country (2017-2022) Table 39. Global Endocrinology Drugs Sales by Type (2017-2022) & (K Units) Table 40. Global Endocrinology Drugs Sales Market Share by Type (2017-2022) Table 41. Global Endocrinology Drugs Revenue by Type (2017-2022) & (US$ Million) Table 42. Global Endocrinology Drugs Revenue Share by Type (2017-2022) Table 43. Global Endocrinology Drugs Price by Type (2017-2022) & (USD/Unit) Table 44. Global Endocrinology Drugs Sales (K Units) by Application (2017-2022) Table 45. Global Endocrinology Drugs Sales Market Share by Application (2017-2022) Table 46. Global Endocrinology Drugs Revenue by Application (2017-2022) & (US$ Million) Table 47. Global Endocrinology Drugs Revenue Share by Application (2017-2022) Table 48. Global Endocrinology Drugs Price by Application (2017-2022) & (USD/Unit) Table 49. AbbVie Corporation Information Table 50. AbbVie Description and Business Overview Table 51. AbbVie Endocrinology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 52. AbbVie Endocrinology Drugs Product Table 53. AbbVie Recent Developments/Updates Table 54. AstraZeneca Corporation Information Table 55. AstraZeneca Description and Business Overview Table 56. AstraZeneca Endocrinology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 57. AstraZeneca Endocrinology Drugs Product Table 58. AstraZeneca Recent Developments/Updates Table 59. Eli Lilly Corporation Information Table 60. Eli Lilly Description and Business Overview Table 61. Eli Lilly Endocrinology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 62. Eli Lilly Endocrinology Drugs Product Table 63. Eli Lilly Recent Developments/Updates Table 64. Merck Corporation Information Table 65. Merck Description and Business Overview Table 66. Merck Endocrinology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 67. Merck Endocrinology Drugs Product Table 68. Merck Recent Developments/Updates Table 69. Novo Nordisk Corporation Information Table 70. Novo Nordisk Description and Business Overview Table 71. Novo Nordisk Endocrinology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 72. Novo Nordisk Endocrinology Drugs Product Table 73. Novo Nordisk Recent Developments/Updates Table 74. Sanofi Corporation Information Table 75. Sanofi Description and Business Overview Table 76. Sanofi Endocrinology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 77. Sanofi Endocrinology Drugs Product Table 78. Sanofi Recent Developments/Updates Table 79. Production Base and Market Concentration Rate of Raw Material Table 80. Key Suppliers of Raw Materials Table 81. Endocrinology Drugs Distributors List Table 82. Endocrinology Drugs Customers List Table 83. Endocrinology Drugs Market Trends Table 84. Endocrinology Drugs Market Drivers Table 85. Endocrinology Drugs Market Challenges Table 86. Endocrinology Drugs Market Restraints Table 87. Global Endocrinology Drugs Sales Forecast by Type (2023-2028) & (K Units) Table 88. Global Endocrinology Drugs Sales Market Share Forecast by Type (2023-2028) Table 89. Global Endocrinology Drugs Revenue Forecast by Type (2023-2028) & (US$ Million) Table 90. Global Endocrinology Drugs Revenue Market Share Forecast by Type (2023-2028) Table 91. Global Endocrinology Drugs Sales Forecast by Application (2023-2028) & (K Units) Table 92. Global Endocrinology Drugs Sales Market Share Forecast by Application (2023-2028) Table 93. Global Endocrinology Drugs Revenue Forecast by Application (2023-2028) & (US$ Million) Table 94. Global Endocrinology Drugs Revenue Market Share Forecast by Application (2023-2028) Table 95. Global Endocrinology Drugs Sales Forecast by Region (2023-2028) & (K Units) Table 96. Global Endocrinology Drugs Sales Market Share Forecast by Region (2023-2028) Table 97. Global Endocrinology Drugs Revenue Forecast by Region (2023-2028) & (US$ Million) Table 98. Global Endocrinology Drugs Revenue Market Share Forecast by Region (2023-2028) Table 99. Research Programs/Design for This Report Table 100. Key Data Information from Secondary Sources Table 101. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Endocrinology Drugs Figure 2. Global Endocrinology Drugs Market Share by Type in 2021 & 2028 Figure 3. Diabetes Drugs Product Picture Figure 4. Testosterone Replacement Drugs Product Picture Figure 5. Human Growth Hormone Drugs Product Picture Figure 6. Thyroid Hormone Disorder Drugs Product Picture Figure 7. Global Endocrinology Drugs Market Share by Application in 2021 & 2028 Figure 8. Hospitals Figure 9. Commercial Laboratories Figure 10. Ambulatory Care Centres Figure 11. Other Setting Figure 12. Global Endocrinology Drugs Revenue, (US$ Million), 2017 VS 2021 VS 2028 Figure 13. Global Endocrinology Drugs Market Size (2017-2028) & (US$ Million) Figure 14. Global Endocrinology Drugs Sales (2017-2028) & (K Units) Figure 15. Endocrinology Drugs Sales Share by Manufacturers in 2021 Figure 16. Global Endocrinology Drugs Revenue Share by Manufacturers in 2021 Figure 17. The Global 5 and 10 Largest Endocrinology Drugs Players: Market Share by Revenue in 2021 Figure 18. Endocrinology Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021 Figure 19. Global Endocrinology Drugs Sales Market Share by Region (2017-2022) Figure 20. Global Endocrinology Drugs Sales Market Share by Region in 2021 Figure 21. Global Endocrinology Drugs Revenue Market Share by Region (2017-2022) Figure 22. Global Endocrinology Drugs Revenue Market Share by Region in 2021 Figure 23. U.S. Endocrinology Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 24. Canada Endocrinology Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 25. Germany Endocrinology Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 26. France Endocrinology Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 27. U.K. Endocrinology Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 28. Italy Endocrinology Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 29. Russia Endocrinology Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 30. China Endocrinology Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 31. Japan Endocrinology Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 32. South Korea Endocrinology Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 33. India Endocrinology Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 34. Australia Endocrinology Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 35. Taiwan Endocrinology Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 36. Indonesia Endocrinology Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 37. Thailand Endocrinology Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 38. Malaysia Endocrinology Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 39. Philippines Endocrinology Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 40. Vietnam Endocrinology Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 41. Mexico Endocrinology Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 42. Brazil Endocrinology Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 43. Argentina Endocrinology Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 44. Turkey Endocrinology Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 45. Saudi Arabia Endocrinology Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 46. U.A.E Endocrinology Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 47. Sales Market Share of Endocrinology Drugs by Type (2017-2022) Figure 48. Manufacturing Cost Structure of Endocrinology Drugs Figure 49. Manufacturing Process Analysis of Endocrinology Drugs Figure 50. Endocrinology Drugs Industrial Chain Analysis Figure 51. Channels of Distribution Figure 52. Distributors Profiles Figure 53. Bottom-up and Top-down Approaches for This Report Figure 54. Data Triangulation Figure 55. Key Executives Interviewed

AbbVie AstraZeneca Eli Lilly Merck Novo Nordisk Sanofi